首页> 外文期刊>The American Journal of Medicine >Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
【24h】

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin

机译:服用华法林的房颤患者HAS-BLED,ATRIA和ORBIT出血风险评分的评估

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: Various bleeding risk prediction schemes, such as the Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized Ratio, Elderly, Drugs/alcohol (HAS-BLED), Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA), and Outcomes Registry for Better Informed Treatment (ORBIT) scores, have been proposed in patients with atrial fibrillation. We compared the relative predictive values of these bleeding risk scores for clinically relevant bleeding and the relationship of ATRIA and ORBIT scores to the quality of anticoagulation control on warfarin, as reflected by time in therapeutic range.
机译:目标:各种出血风险预测方案,例如高血压,肾/肝功能异常,中风,出血史或易感性,不稳定的国际标准化比率,老年人,药物/酒精(HAS-BLED),抗凝和心房颤动的危险因素(对于房颤患者,已经提出了ATRIA)和更好的知情治疗结果注册(ORBIT)评分。我们比较了这些出血风险评分对临床相关出血的相对预测值以及ATRIA和ORBIT评分与华法林抗凝控制质量的关系,如治疗范围内的时间所反映。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号